A phase II Southwest Oncology Group study of cisplatin and continuous infusion vinblastine in the treatment of advanced soft tissue sarcoma

Investigational New Drugs

Volumn 15, Issue 3, 1997, Pages 255-256

  Keohan, Mary Lou ^a   Grever, Michael R ^b   Balcerzak, Stanley P ^c   Antman, Karen ^a  

^a Columbia University ^*  (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Chemotherapy; Cisplatin; Soft tissue sarcoma; Vinblastine

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; IFOSFAMIDE; VINBLASTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SOFT TISSUE SARCOMA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; FEMALE; HUMANS; MALE; MIDDLE AGED; SARCOMA; VINBLASTINE;

EID: 0030657795     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005803921371     Document Type: Article

References (4)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA A Cancer Journal for Clinicians 46: 5-27, 1996.
2. Yang JC, Rosenberg SA. Glatstein E, Antman K. Sarcomas of soft tissue. In: De Vita VT HSRS, ed. Cancer Principals & Practice of Oncology, 3rd ed. Philadelphia. J.B. Lippincott: 1436-1488, 1993.
3. Karakousis CP, Holterman OA, Holyoke E. Cisdichlorodi-amineplatinum (II) in metastatic soft tissue sarcomas. Cancer Treat Rep 63: 2071-2075, 1979.
4. Yap HY, Blumenschein GR, Keeting M, Hortobagyi GN, Tashima CK, Loo TL. Vinblastine given as continuous 5 day infusion in the treatment of refractory advanced breast cancer. Cancer Treat Rep 64: 279, 1980.